New hope for kids with cystic fibrosis: drug may ease sinus troubles
NCT ID NCT05581056
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 27 times
Summary
This study looked at whether CFTR modulators (like Kaftrio) improve nose and sinus symptoms and quality of life in children aged 6 to 11 with cystic fibrosis. Researchers measured symptom changes using a special questionnaire before and one year after starting treatment. The goal was to see if these drugs help beyond just lung function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Femme Mère Enfant
Bron, Rhone, 69500, France
Conditions
Explore the condition pages connected to this study.